Organon & Co (OGN)
14.89
+0.16
(+1.09%)
USD |
NYSE |
Nov 21, 16:00
14.99
+0.10
(+0.67%)
After-Hours: 20:00
Organon Enterprise Value: 11.82B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 11.82B |
| November 20, 2024 | 11.78B |
| November 19, 2024 | 11.74B |
| November 18, 2024 | 11.87B |
| November 15, 2024 | 11.86B |
| November 14, 2024 | 11.93B |
| November 13, 2024 | 12.01B |
| November 12, 2024 | 12.00B |
| November 11, 2024 | 12.13B |
| November 08, 2024 | 12.12B |
| November 07, 2024 | 12.14B |
| November 06, 2024 | 12.06B |
| November 05, 2024 | 12.23B |
| November 04, 2024 | 12.34B |
| November 01, 2024 | 12.64B |
| October 31, 2024 | 12.82B |
| October 30, 2024 | 12.60B |
| October 29, 2024 | 12.58B |
| October 28, 2024 | 12.48B |
| October 25, 2024 | 12.41B |
| October 24, 2024 | 12.42B |
| October 23, 2024 | 12.42B |
| October 22, 2024 | 12.45B |
| October 21, 2024 | 12.48B |
| October 18, 2024 | 12.52B |
| Date | Value |
|---|---|
| October 17, 2024 | 12.53B |
| October 16, 2024 | 12.61B |
| October 15, 2024 | 12.63B |
| October 14, 2024 | 12.65B |
| October 11, 2024 | 12.62B |
| October 10, 2024 | 12.62B |
| October 09, 2024 | 12.63B |
| October 08, 2024 | 12.65B |
| October 07, 2024 | 12.65B |
| October 04, 2024 | 12.70B |
| October 03, 2024 | 12.69B |
| October 02, 2024 | 12.77B |
| October 01, 2024 | 12.84B |
| September 30, 2024 | 12.91B |
| September 27, 2024 | 12.89B |
| September 26, 2024 | 12.89B |
| September 25, 2024 | 12.85B |
| September 24, 2024 | 13.01B |
| September 23, 2024 | 13.03B |
| September 20, 2024 | 12.97B |
| September 19, 2024 | 13.15B |
| September 18, 2024 | 13.09B |
| September 17, 2024 | 13.24B |
| September 16, 2024 | 13.33B |
| September 13, 2024 | 13.22B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.592B
Minimum
Jun 09 2021
18.38B
Maximum
Mar 02 2022
14.46B
Average
14.23B
Median
Mar 08 2023
Enterprise Value Benchmarks
| Eli Lilly and Co | 739.59B |
| ResMed Inc | 36.01B |
| TG Therapeutics Inc | 5.281B |
| Sage Therapeutics Inc | -272.46M |
| Applied Therapeutics Inc | 979.76M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 359.00M |
| Revenue (Quarterly) | 1.582B |
| Total Expenses (Quarterly) | 1.192B |
| EPS Diluted (Quarterly) | 1.38 |
| Gross Profit Margin (Quarterly) | 58.34% |
| Profit Margin (Quarterly) | 22.69% |
| Earnings Yield | 33.85% |
| Operating Earnings Yield | 39.05% |
| Normalized Earnings Yield | 37.84 |